Literature DB >> 2931219

Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.

J A Werkmeister, A W Boyd, T Triglia, G F Burns.   

Abstract

Blood from patients with hairy cell leukaemia (HCL) was used to investigate subpopulations of the non-specific activated lymphocyte killer (ALK) cells generated in mixed lymphocyte culture (MLC). Mononuclear cells from four of five patients with HCL had decreased natural killer (NK) cell activity and, of these, all showed a decrease in ALK cell activity against K-562 target cells (NK like cells), but three had normal levels of ALK cells able to kill melanoma cells. One patient who had received splenectomy had normal NK cell activity, and in MLC his cells generated normal levels of both subpopulations of ALK cells. The results support the hypothesis of separate subsets of ALK cells: NK like cells with NK cell precursors and which preferentially lyse the K-562 target cell and a second separate population which arises independent of NK cell precursors and which has strong cytolytic activity against an NK insensitive melanoma cell line.

Entities:  

Mesh:

Year:  1985        PMID: 2931219      PMCID: PMC1577230     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Authors:  J M Zarling; H I Robins; P C Raich; F H Bach; M L Bach
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

2.  The effect of target cell differentiation on human natural killer cell activity: a specific defect in target cell binding and early activation events.

Authors:  J A Werkmeister; S L Helfand; T Haliotis; H F Pross; J C Roder
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Ultrastructural characteristics of human T cell clones with various cytolytic activities.

Authors:  C E Grossi; A Zicca; A Cadoni; M C Mingari; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

4.  Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.

Authors:  L P Ruco; A Procopio; V Maccallini; A Calogero; S Uccini; L Annino; F Mandelli; C D Baroni
Journal:  Blood       Date:  1983-06       Impact factor: 22.113

5.  Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.

Authors:  G Strassmann; F H Bach; J M Zarling
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

6.  Development of large granular lymphocytes with anomalous, nonspecific cytotoxicity in clones derived from Ly-2+ T cells.

Authors:  K Shortman; A Wilson; R Scollay; W F Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity.

Authors:  G P Pawelec; M R Hadam; A Ziegler; J Lohmeyer; A Rehbein; I Kumbier; P Wernet
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

8.  A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia.

Authors:  J C Cawley; G F Burns; F G Hayhoe
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

9.  Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.

Authors:  N Flomenberg; K Welte; R Mertelsmann; R O'Reilly; B Dupont
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes.

Authors:  C G Brooks
Journal:  Nature       Date:  1983 Sep 8-14       Impact factor: 49.962

View more
  1 in total

1.  Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.

Authors:  A M Liberati; V De Angelis; M Fizzotti; M Schippa; M Cecchini; D Adiuto; F Di Clemente; L Palmisano; E Micozzi; M Zuccaccia
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.